Skip to main content
An official website of the United States government
Español

AP23573

A substance being studied in the treatment of soft tissue and bone cancers. It is also being studied in the treatment of other solid tumors and hematologic cancer. AP23573 stops cells from dividing and may cause cancer cells to die. It is a type of mTOR inhibitor. Also called ridaforolimus.
Search NCI's Dictionary of Cancer Terms